Inventor · disambiguated record
Shyh-Ming Yang
Also filed as: YANG SHYH · YANG SHYH-MING
23 granted patents·3 pending applications·31 citations·filing 2006–2024
92Inventor score
Files withJANSSEN PHARMACEUTICA NV10US HEALTH5CONVERGENE LLC3CHAKRAVARTY DEVRAJ1NAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES1
Top patents by PatentIndex Score
26 records- 0194US11247971B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2021·Granted Feb 15, 2022·3 cites·17 claims
- 0290US10961200B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2019·Granted Mar 30, 2021·4 cites·18 claims
- 0389US10351532B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUNIV VANDERBILT·Filed 2015·Granted Jul 16, 2019·8 cites·21 claims
- 0486US12365653B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2024·Granted Jul 22, 2025·0 cites·12 claims
- 0582US10508106B2Bicyclic BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2016·Granted Dec 17, 2019·2 cites·2 claims
- 0682US10214493B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 26, 2019·3 cites·13 claims
- 0780US10000473B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 19, 2018·3 cites·20 claims
- 0879US7803793B2Heterocyclic derived metalloprotease inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·5 cites·32 claims
- 0976US11897845B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2022·Granted Feb 13, 2024·0 cites·19 claims
- 1073US10954228B21 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereofNAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 23, 2021·2 cites·18 claims
- 1169US11098016B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 24, 2021·0 cites·12 claims
- 1265US11795177B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2022·Granted Oct 24, 2023·0 cites·22 claims
- 1365US10662170B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 26, 2020·0 cites·2 claims
- 1461US8748624B2Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 10, 2014·1 cites·22 claims
- 1559US10774048B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 15, 2020·0 cites·10 claims
- 1658US11028079B2Small molecule BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2019·Granted Jun 8, 2021·0 cites·14 claims
- 1758US10131648B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 20, 2018·0 cites·14 claims
- 1854US11505559B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2018·Granted Nov 22, 2022·0 cites·18 claims
- 1953US11426415B2Treatment for Wolfram syndrome and other endoplasmic reticulum stress disordersUNIV WASHINGTON·Filed 2018·Granted Aug 30, 2022·0 cites·11 claims
- 2053US9790198B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 17, 2017·0 cites·22 claims
- 2148US12497395B2Small molecule bromodomain inhibitors and uses therofCONVERGENE LLC·Filed 2020·Granted Dec 16, 2025·0 cites·13 claims
- 2245US2008085893A1Matrix metalloprotease inhibitorsYANG SHYH-MING·Filed 2007·Application pending·0 cites
- 2344US9238658B2Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 19, 2016·0 cites·13 claims
- 2442US9102669B2Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Aug 11, 2015·0 cites·13 claims
- 2539US2007249590A1Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disordersWILSON LAWRENCE J·Filed 2006·Application pending·0 cites
- 2634US2010279986A1Heterocyclic derived metalloprotease inhibitorsZHANG YUE-MEI·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →